GILEAD SCIENCES, INC. Logo

GILEAD SCIENCES, INC.

A research-based biopharmaceutical company focused on virology, oncology & inflammation.

GILD | US

Overview

Corporate Details

ISIN(s):
US3755581036
LEI:
Country:
United States of America
Address:
333 LAKESIDE DR, 94404 FOSTER CITY

Description

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes innovative medicines to address unmet medical needs. The company's primary focus is on virology, with a portfolio of transformative therapies for life-threatening diseases such as HIV/AIDS and viral hepatitis. Gilead is also expanding its impact in oncology and inflammation, maintaining a diverse pipeline of clinical programs across these key therapeutic areas. The company invests in scientific research to develop treatments for some of the world's most challenging diseases, aiming to improve the lives of patients globally.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-01 19:11
FORM 4
English 7.3 KB
2025-12-01 17:54
FORM 4
English 7.5 KB
2025-12-01 17:50
FORM 4
English 7.2 KB
2025-12-01 17:36
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
English 8.2 KB
2025-11-28 14:05 English 7.1 KB
2025-11-28 14:02 English 7.0 KB
2025-11-26 17:16 English 7.1 KB
2025-11-19 09:30
FORM 8-K
English 64.3 KB
2025-11-18 20:00
FORM 4
English 6.7 KB
2025-11-18 19:51
FORM 4
English 7.8 KB
2025-11-17 17:06 English 7.2 KB
2025-11-17 17:05 English 7.3 KB
2025-11-13 20:36
FORM 4
English 8.3 KB
2025-11-13 18:07 English 6.8 KB
2025-11-13 17:44 English 7.9 KB

Automate Your Workflow. Get a real-time feed of all GILEAD SCIENCES, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GILEAD SCIENCES, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GILEAD SCIENCES, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alzinova AB Logo
Clinical-stage biopharma developing immunotherapies for Alzheimer's disease.
Sweden
ALZ
AMARIN CORP PLC\UK Logo
Develops and commercializes therapeutics to improve cardiovascular health.
United States of America
AMRN
AMGEN INC Logo
A biotechnology company developing human therapeutics for serious illnesses.
United States of America
AMGN
Industrial biotechnology company specializing in specialty enzymes and proteins.
South Korea
092040
AMICUS THERAPEUTICS, INC. Logo
Biotechnology company developing therapies for rare genetic and devastating diseases.
United States of America
FOLD
AMINOLOGICS CO.,LTD. Logo
Specialty manufacturer of high-purity chiral amino acids and their derivatives.
South Korea
074430
Amneal Pharmaceuticals, Inc. Logo
Develops, manufactures, and distributes generic and specialty pharmaceuticals.
United States of America
AMRX
Amphastar Pharmaceuticals, Inc. Logo
Develops, manufactures, and markets technically challenging medications.
United States of America
AMPH
Amylyx Pharmaceuticals, Inc. Logo
Develops therapies for neurodegenerative diseases and other unmet medical needs.
United States of America
AMLX
AN2 Therapeutics, Inc. Logo
Biopharmaceutical firm developing boron-based drugs for infectious diseases.
United States of America
ANTX

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.